Free Trial

Scopus BioPharma (SCPS) Competitors

Scopus BioPharma logo
$0.0003 0.00 (0.00%)
As of 03:13 PM Eastern

SCPS vs. HSTO, VAXX, EVLO, CMRA, GNCAQ, GNCA, ARDS, STAB, CLVR, and EFTR

Should you be buying Scopus BioPharma stock or one of its competitors? The main competitors of Scopus BioPharma include Histogen (HSTO), Vaxxinity (VAXX), Evelo Biosciences (EVLO), Comera Life Sciences (CMRA), Genocea Biosciences (GNCAQ), Genocea Biosciences (GNCA), Aridis Pharmaceuticals (ARDS), Statera Biopharma (STAB), Clever Leaves (CLVR), and eFFECTOR Therapeutics (EFTR). These companies are all part of the "pharmaceutical products" industry.

Scopus BioPharma vs. Its Competitors

Scopus BioPharma (NASDAQ:SCPS) and Histogen (NASDAQ:HSTO) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations, risk and media sentiment.

Histogen has higher revenue and earnings than Scopus BioPharma.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Scopus BioPharmaN/AN/A-$11.61MN/AN/A
Histogen$19K0.07-$10.62M-$2.810.00

In the previous week, Scopus BioPharma's average media sentiment score of 0.00 equaled Histogen'saverage media sentiment score.

Company Overall Sentiment
Scopus BioPharma Neutral
Histogen Neutral

Company Net Margins Return on Equity Return on Assets
Scopus BioPharmaN/A N/A N/A
Histogen N/A N/A N/A

Scopus BioPharma has a beta of -0.19, meaning that its stock price is 119% less volatile than the S&P 500. Comparatively, Histogen has a beta of 1.19, meaning that its stock price is 19% more volatile than the S&P 500.

Summary

Histogen beats Scopus BioPharma on 3 of the 3 factors compared between the two stocks.

Get Scopus BioPharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for SCPS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SCPS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SCPS vs. The Competition

MetricScopus BioPharmaPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$13K$780.02M$5.47B$8.95B
Dividend YieldN/A4.84%5.25%4.06%
P/E RatioN/A1.0927.0020.10
Price / SalesN/A230.52435.75120.29
Price / CashN/A23.4436.8257.86
Price / BookN/A6.137.985.56
Net Income-$11.61M-$27.85M$3.16B$248.40M
7 Day PerformanceN/A2.14%3.69%6.04%
1 Month PerformanceN/A8.33%2.91%7.69%
1 Year PerformanceN/A8.62%34.30%20.97%

Scopus BioPharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SCPS
Scopus BioPharma
N/A$0.00
flat
N/A+50.0%$13KN/A0.009
HSTO
Histogen
N/A$0.01
flat
N/A-99.9%$43K$19K0.0020
VAXX
Vaxxinity
N/A$0.00
flat
N/A-87.4%$13KN/A0.0090News Coverage
EVLO
Evelo Biosciences
N/A$0.00
flat
N/AN/A$9KN/A0.00120
CMRA
Comera Life Sciences
N/A$0.00
flat
N/A-99.3%$6K$1.00M0.002
GNCAQ
Genocea Biosciences
N/AN/AN/AN/A$6KN/A0.0070
GNCA
Genocea Biosciences
N/AN/AN/AN/A$6K$1.91M0.0070
ARDS
Aridis Pharmaceuticals
N/A$0.00
flat
N/A-99.9%$5K$3.09M0.0030
STAB
Statera Biopharma
N/A$0.00
flat
N/A-83.3%$5KN/A0.0020
CLVR
Clever Leaves
N/A$0.00
flat
N/AN/A$1K$17.42M0.00560
EFTR
eFFECTOR Therapeutics
N/A$0.00
flat
N/A-99.8%$1K$3.55M0.0010Gap Down

Related Companies and Tools


This page (NASDAQ:SCPS) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners